1. Home
  2. NSPR vs VANI Comparison

NSPR vs VANI Comparison

Compare NSPR & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • VANI
  • Stock Information
  • Founded
  • NSPR 2005
  • VANI 1998
  • Country
  • NSPR Israel
  • VANI United States
  • Employees
  • NSPR N/A
  • VANI N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NSPR Health Care
  • VANI Health Care
  • Exchange
  • NSPR Nasdaq
  • VANI Nasdaq
  • Market Cap
  • NSPR 75.6M
  • VANI 65.2M
  • IPO Year
  • NSPR N/A
  • VANI 2014
  • Fundamental
  • Price
  • NSPR $2.58
  • VANI $1.03
  • Analyst Decision
  • NSPR Strong Buy
  • VANI Strong Buy
  • Analyst Count
  • NSPR 2
  • VANI 1
  • Target Price
  • NSPR $4.75
  • VANI $4.00
  • AVG Volume (30 Days)
  • NSPR 67.4K
  • VANI 102.7K
  • Earning Date
  • NSPR 03-12-2025
  • VANI 03-31-2025
  • Dividend Yield
  • NSPR N/A
  • VANI N/A
  • EPS Growth
  • NSPR N/A
  • VANI N/A
  • EPS
  • NSPR N/A
  • VANI N/A
  • Revenue
  • NSPR $7,009,000.00
  • VANI N/A
  • Revenue This Year
  • NSPR $50.18
  • VANI N/A
  • Revenue Next Year
  • NSPR $159.56
  • VANI N/A
  • P/E Ratio
  • NSPR N/A
  • VANI N/A
  • Revenue Growth
  • NSPR 12.96
  • VANI N/A
  • 52 Week Low
  • NSPR $1.81
  • VANI $1.03
  • 52 Week High
  • NSPR $3.80
  • VANI $2.22
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 39.79
  • VANI 36.53
  • Support Level
  • NSPR $2.57
  • VANI $1.06
  • Resistance Level
  • NSPR $2.78
  • VANI $1.16
  • Average True Range (ATR)
  • NSPR 0.16
  • VANI 0.04
  • MACD
  • NSPR -0.01
  • VANI -0.00
  • Stochastic Oscillator
  • NSPR 31.82
  • VANI 3.85

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.

Share on Social Networks: